2012

• Coates, A., Millar, E., O'Toole, S., Molloy, T., Viale, G., Goldhirsch, A., Regan, M., Gelber, R., Sun, Z., Castiglione-Gertsch, M., Gusterson, B., Musgrove, E., Sutherland, R. (2012), Prognostic interaction between expression of p53 and estrogen receptor in patients with node-negative breast cancer: results from IBCSG Trials VIII and IX. Breast Cancer Research. 14(6), R143. [Abstract]
• Huober, J., Gelber, S., Goldhirsch, A., Coates, A., Viale, G., ÿhlschlegel, C., Price, K., Gelber, R., Regan, M., Thürlimann, B. (2012), Prognosis of medullary breast cancer: analysis of 13 International Breast Cancer Study Group (IBCSG) trials. Annals of Oncology. 23(11), 2843-2851. [Abstract]
• Ewertz, M., Gray, K., Regan, M., Ejlertsen, B., Price, K., Thürlimann, B., Bonnefoi, H., Forbes, J., Paridaens, R., Rabaglio, M., Gelber, R., Colleoni, M., Láng, I., Smith, I., Coates, A., Goldhirsch, A., Mouridsen, H. (2012), Obesity and Risk of Recurrence or Death After Adjuvant Endocrine Therapy With Letrozole or Tamoxifen in the Breast International Group 1-98 Trial. Journal of Clinical Oncology. 30(32), 3967-3975. [Abstract]
• Ribi, K., Aldridge, J., Phillips, K., Thompson, A., Harvey, V., Thürlimann, B., Cardoso, F., Pagani, O., Coates, A., Goldhirsch, A., Price, K., Gelber, R., Bernhard, J. (2012), Subjective cognitive complaints one year after ceasing adjuvant endocrine treatment for early-stage breast cancer. British Journal of Cancer. 106(10), 1618-1625. [Abstract]
• Coates, A., Colleoni, M., Goldhirsch, A. (2012), Is adjuvant chemotherapy useful for women with luminal a breast cancer?. Journal of Clinical Oncology. 30(12), 1260-1263. [Abstract]
• Regan, M., Leyland-Jones, B., Bouzyk, M., Pagani, O., Tang, W., Kammler, R., Dell'orto, P., Biasi, M., Thürlimann, B., Lyng, M., Ditzel, H., Neven, P., Debled, M., Maibach, R., Price, K., Gelber, R., Coates, A., Goldhirsch, A., Rae, J., Viale, G. (2012), CYP2D6 genotype and tamoxifen response in postmenopausal women with endocrine-responsive breast cancer: the breast international group 1-98 trial. Journal of the National Cancer Institute. 104(6), 441-451. [Abstract]
• Bliss, J., Kilburn, L., Coleman, R., Forbes, J., Coates, A., Jones, S., Jassem, J., Delozier, T., Andersen, J., Paridaens, R., van de Velde, C., Lonning, P., Morden, J., Reise, J., Cisar, L., Menschik, T., Coombes, R. (2012), Disease-Related Outcomes With Long-Term Follow-Up: An Updated Analysis of the Intergroup Exemestane Study. Journal of Clinical Oncology. 30(7), 709-717. [Abstract]
• Chirgwin, J., Sun, Z., Smith, I., Price, K., Thürlimann, B., Ejlertsen, B., Bonnefoi, H., Regan, M., Goldhirsch, A., Coates, A. (2012), The advantage of letrozole over tamoxifen in the BIG 1-98 trial is consistent in younger postmenopausal women and in those with chemotherapy-induced menopause. Breast cancer research and treatment. 131(1), 295-306. [Abstract]

2011

• Stockler, M., Harvey, V., Francis, P., Byrne, M., Ackland, S., Fitzharris, B., Van Hazel, G., Wilcken, N., Grimison, P., Nowak, A., Gainford, M., Fong, A., Paksec, L., Sourjina, T., Zannino, D., Gebski, V., Simes, R., Forbes, J., Coates, A. (2011), Capecitabine Versus Classical Cyclophosphamide, Methotrexate, and Fluorouracil As First-Line Chemotherapy for Advanced Breast Cancer. Journal of Clinical Oncology. 29(34), 4498-4504. [Abstract]
• Regan, M., Neven, P., Giobbie-Hurder, A., Goldhirsch, A., Ejlertsen, B., Mauriac, L., Forbes, J., Smith, I., Láng, I., Wardley, A., Rabaglio, M., Price, K., Gelber, R., Coates, A., Thürlimann, B. (2011), Assessment of letrozole and tamoxifen alone and in sequence for postmenopausal women with steroid hormone receptor-positive breast cancer: the BIG 1-98 randomised clinical trial at 8·1 years median follow-up. The lancet oncology. 12(12), 1101-8. [Abstract]
• Viale, G., Regan, M., Dell'orto, P., Mastropasqua, M., Maiorano, E., Rasmussen, B., Macgrogan, G., Forbes, J., Paridaens, R., Colleoni, M., Láng, I., Thürlimann, B., Mouridsen, H., Mauriac, L., Gelber, R., Price, K., Goldhirsch, A., Gusterson, B., Coates, A. (2011), Which patients benefit most from adjuvant aromatase inhibitors? Results using a composite measure of prognostic risk in the BIG 1-98 randomized trial. Annals of oncology : official journal of the European Society for Medical Oncology / ESMO. 22(10), 2201-7. [Abstract]
• Karlsson, P., Sun, Z., Braun, D., Price, K., Castiglione-Gertsch, M., Rabaglio, M., Gelber, R., Crivellari, D., Collins, J., Murray, E., Zaman, K., Colleoni, M., Gusterson, B., Viale, G., Regan, M., Coates, A., Goldhirsch, A. (2011), Long-term results of International Breast Cancer Study Group Trial VIII: adjuvant chemotherapy plus goserelin compared with either therapy alone for premenopausal patients with node-negative breast cancer. Annals of oncology : official journal of the European Society for Medical Oncology / ESMO. 22(10), 2216-26. [Abstract]
• Aebi, S., Sun, Z., Braun, D., Price, K., Castiglione-Gertsch, M., Rabaglio, M., Gelber, R., Crivellari, D., Lindtner, J., Snyder, R., Karlsson, P., Simoncini, E., Gusterson, B., Viale, G., Regan, M., Coates, A., Goldhirsch, A. (2011), Differential efficacy of three cycles of CMF followed by tamoxifen in patients with ER-positive and ER-negative tumors: Long-term follow up on IBCSG Trial IX. Annals of oncology : official journal of the European Society for Medical Oncology / ESMO. 22(9), 1981-7. [Abstract]
• Lee, C., Hudson, M., Stockler, M., Coates, A., Ackland, S., Gebski, V., Lord, S., Friedlander, M., Boyle, F., Simes, R. (2011), A nomogram to predict survival time in women starting first-line chemotherapy for advanced breast cancer. Breast cancer research and treatment. 129(2), 467-76. [Abstract]
• Goldhirsch, A., Wood, W., Coates, A., Gelber, R., Thürlimann, B., Senn, H. (2011), Strategies for subtypes--dealing with the diversity of breast cancer: highlights of the St. Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2011. Annals of Oncology. 22(8), 1736-1747. [Abstract]
• Colleoni, M., Giobbie-Hurder, A., Regan, M., Thürlimann, B., Mouridsen, H., Mauriac, L., Forbes, J., Paridaens, R., Láng, I., Smith, I., Chirgwin, J., Pienkowski, T., Wardley, A., Price, K., Gelber, R., Coates, A., Goldhirsch, A. (2011), Analyses adjusting for selective crossover show improved overall survival with adjuvant letrozole compared with tamoxifen in the BIG 1-98 study. Journal of Clinical Oncology. 29(9), 1117-1124. [Abstract]
• Phillips, K., Aldridge, J., Ribi, K., Sun, Z., Thompson, A., Harvey, V., Thürlimann, B., Cardoso, F., Pagani, O., Coates, A., Goldhirsch, A., Price, K., Gelber, R., Bernhard, J. (2011), Cognitive function in postmenopausal breast cancer patients one year after completing adjuvant endocrine therapy with letrozole and/or tamoxifen in the BIG 1-98 trial. Breast Cancer Research and Treatment. 126(1), 221-226. [Abstract]

2010

• Castellano, I., Allia, E., Accortanzo, V., Vandone, A., Chiusa, L., Arisio, R., Durando, A., Donadio, M., Bussolati, G., Coates, A., Viale, G., Sapino, A. (2010), Androgen receptor expression is a significant prognostic factor in estrogen receptor positive breast cancers. Breast cancer research and treatment. 124, 607-17. [Abstract]
• Phillips, K., Ribi, K., Sun, Z., Stephens, A., Thompson, A., Harvey, V., Thürlimann, B., Cardoso, F., Pagani, O., Coates, A., Goldhirsch, A., Price, K., Gelber, R., Bernhard, J. (2010), Cognitive function in postmenopausal women receiving adjuvant letrozole or tamoxifen for breast cancer in the BIG 1-98 randomized trial. Breast (Edinburgh, Scotland). 19(5), 388-95. [Abstract]
• Paridaens, R., Gelber, S., Cole, B., Gelber, R., Thürlimann, B., Price, K., Holmberg, S., Crivellari, D., Coates, A., Goldhirsch, A. (2010), Adjuvant! Online estimation of chemotherapy effectiveness when added to ovarian function suppression plus tamoxifen for premenopausal women with estrogen-receptor-positive breast cancer. Breast Cancer Research and Treatment. 123(1), 303-310. [Abstract]
• Colleoni, M., Cole, B., Viale, G., Regan, M., Price, K., Maiorano, E., Mastropasqua, M., Crivellari, D., Gelber, R., Goldhirsch, A., Coates, A., Gusterson, B. (2010), Classical Cyclophosphamide, Methotrexate, and Fluorouracil Chemotherapy Is More Effective in Triple-Negative, Node-Negative Breast Cancer: Results From Two Randomized Trials of Adjuvant Chemoendocrine Therapy for Node-Negative Breast Cancer. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 28(18), 2966-73. [Abstract]
• Maiorano, E., Regan, M., Viale, G., Mastropasqua, M., Colleoni, M., Castiglione-Gertsch, M., Price, K., Gelber, R., Goldhirsch, A., Coates, A. (2010), Prognostic and predictive impact of central necrosis and fibrosis in early breast cancer: Results from two International Breast Cancer Study Group randomized trials of chemoendocrine adjuvant therapy. Breast cancer research and treatment. 121(1), 211-8. [Abstract]
• Lee, C., Stockler, M., Coates, A., Gebski, V., Lord, S., Simes, R. (2010), Self-reported health-related quality of life is an independent predictor of chemotherapy treatment benefit and toxicity in women with advanced breast cancer. British journal of cancer. 102(9), 1341-7. [Abstract]
• Lee, C., Lord, S., Stockler, M., Coates, A., Gebski, V., Simes, R. (2010), Historical cross-trial comparisons for competing treatments in advanced breast cancer - An empirical analysis of bias. European journal of cancer (Oxford, England : 1990). 46(3), 541-8. [Abstract]
• Viale, G., Giobbie-Hurder, A., Gusterson, B., Maiorano, E., Mastropasqua, M., Sonzogni, A., Mallon, E., Colleoni, M., Castiglione-Gertsch, M., Regan, M., Price, K., Brown, R., Golouh, R., Crivellari, D., Karlsson, P., Ohlschlegel, C., Gelber, R., Goldhirsch, A., Coates, A. (2010), Adverse prognostic value of peritumoral vascular invasion: is it abrogated by adequate endocrine adjuvant therapy? Results from two International Breast Cancer Study Group randomized trials of chemoendocrine adjuvant therapy for early breast cancer. Annals of oncology : official journal of the European Society for Medical Oncology / ESMO. 21(2), 245-54. [Abstract]

2009

• Pagani, O., Price, K., Gelber, R., Castiglione-Gertsch, M., Holmberg, S., Lindtner, J., Thürlimann, B., Collins, J., Fey, M., Coates, A., Goldhirsch, A. (2009), Patterns of recurrence of early breast cancer according to estrogen receptor status: a therapeutic target for a quarter of a century. Breast Cancer Research and Treatment. 117(2), 319-324. [Abstract]
• Rabaglio, M., Sun, Z., Price, K., Castiglione-Gertsch, M., Hawle, H., Thürlimann, B., Mouridsen, H., Campone, M., Forbes, J., Paridaens, R., Colleoni, M., Pienkowski, T., Nogaret, J., Láng, I., Smith, I., Gelber, R., Goldhirsch, A., Coates, A. (2009), Bone fractures among postmenopausal patients with endocrine-responsive early breast cancer treated with 5 years of letrozole or tamoxifen in the BIG 1-98 trial. Annals of oncology. 20(9), 1489-1498. [Abstract]
• Viale, G., Rotmensz, N., Maisonneuve, P., Orvieto, E., Maiorano, E., Galimberti, V., Luini, A., Colleoni, M., Goldhirsch, A., Coates, A. (2009), Lack of prognostic significance of "classic" lobular breast carcinoma: a matched, single institution series. Breast cancer research and treatment. 117(0), 211-4. [Abstract]
• Mouridsen, H., Giobbie-Hurder, A., Goldhirsch, A., Thürlimann, B., Paridaens, R., Smith, I., Mauriac, L., Forbes, J., Price, K., Regan, M., Gelber, R., Coates, A. (2009), Letrozole therapy alone or in sequence with tamoxifen in women with breast cancer. New England Journal of Medicine. 361(8), 766-776. [Abstract]
• Goldhirsch, A., Ingle, J., Gelber, R., Coates, A., Thürlimann, B., Senn, H. (2009), Thresholds for therapies: highlights of the St Gallen International Expert Consensus on the primary therapy of early breast cancer 2009. Annals of Oncology. 20(8), 1319-1329. [Abstract]
• Colleoni, M., Sun, Z., Martinelli, G., Basser, R., Coates, A., Gelber, R., Green, M., Peccatori, F., Cinieri, S., Aebi, S., Viale, G., Price, K., Goldhirsch, A. (2009), The effect of endocrine responsiveness on high-risk breast cancer treated with dose-intensive chemotherapy: results of International Breast Cancer Study Group Trial 15-95 after prolonged follow-up. Annals of Oncology. 20(8), 1344-1351. [Abstract]
• Pagani, O., Gelber, S., Simoncini, E., Castiglione-Gertsch, M., Price, K., Gelber, R., Holmberg, S., Crivellari, D., Collins, J., Lindtner, J., Thürlimann, B., Fey, M., Murray, E., Forbes, J., Coates, A., Goldhirsch, A. (2009), Is adjuvant chemotherapy of benefit for postmenopausal women who receive endocrine treatment for highly endocrine-responsive, node-positive breast cancer? International Breast Cancer Study Group Trials VII and 12-93. Breast Cancer Research and Treatment. 116(3), 491-500. [Abstract]
• Lee, C., Lord, S., Coates, A., Simes, R. (2009), Molecular biomarkers to individualise treatment: assessing the evidence. The Medical Journal of Australia. 190(11), 631-636. [Abstract]
• Gianni, L., Gelber, S., Ravaioli, A., Price, K., Panzini, I., Fantini, M., Castiglione-Gertsch, M., Pagani, O., Simoncini, E., Gelber, R., Coates, A., Goldhirsch, A. (2009), Second non-breast primary cancer following adjuvant therapy for early breast cancer: a report from the International Breast Cancer Study Group. European Journal of Cancer. 45(4), 561-571. [Abstract]
• Thürlimann, B., Price, K., Gelber, R., Holmberg, S., Crivellari, D., Colleoni, M., Collins, J., Forbes, J., Castiglione-Gertsch, M., Coates, A., Goldhirsch, A. (2009), Is chemotherapy necessary for premenopausal women with lower-risk node-positive, endocrine responsive breast cancer? 10-year update of International Breast Cancer Study Group Trial 11-93. Breast cancer research and treatment. 113(1), 137-44. [Abstract]

2008

• Viale, G., Giobbie-Hurder, A., Regan, M., Coates, A., Mastropasqua, M., Dell'orto, P., Maiorano, E., Macgrogan, G., Braye, S., Ohlschlegel, C., Neven, P., Orosz, Z., Olszewski, W., Knox, F., Thürlimann, B., Price, K., Castiglione-Gertsch, M., Gelber, R., Gusterson, B., Goldhirsch, A. (2008), Prognostic and Predictive Value of Centrally Reviewed Ki-67 Labeling Index in Postmenopausal Women With Endocrine-Responsive Breast Cancer: Results From Breast International Group Trial 1-98 Comparing Adjuvant Tamoxifen With Letrozole. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 26(34), 5569-75. [Abstract]
• Juraskova, I., Butow, P., Lopez, A., Seccombe, M., Coates, A., Boyle, F., McCarthy, N., Reaby, L., Forbes, J. (2008), Improving informed consent: pilot of a decision aid for women invited to participate in a breast cancer prevention trial (IBIS-II DCIS). Health Expectations. 11(3), 252-262. [Abstract]
• Duric, V., Butow, P., Sharpe, L., Heritier, S., Boyle, F., Beith, J., Wilcken, N., Coates, A., Simes, R., Stockler, M. (2008), Comparing patients' and their partners' preferences for adjuvant chemotherapy in early breast cancer. Patient Education and Counseling. 72(2), 239-245. [Abstract]
• Gruber, G., Cole, B., Castiglione-Gertsch, M., Holmberg, S., Lindtner, J., Golouh, R., Collins, J., Crivellari, D., Thürlimann, B., Simoncini, E., Fey, M., Gelber, R., Coates, A., Price, K., Goldhirsch, A., Viale, G., Gusterson, B. (2008), Extracapsular tumor spread and the risk of local, axillary and supraclavicular recurrence in node-positive, premenopausal patients with breast cancer. Annals of Oncology. 19(8), 1393-1401. [Abstract]
• Regan, M., Pagani, O., Walley, B., Torrisi, R., Perez, E., Francis, P., Fleming, G., Price, K., Thürlimann, B., Maibach, R., Castiglione-Gertsch, M., Coates, A., Goldhirsch, A., Gelber, R. (2008), Premenopausal endocrine-responsive early breast cancer: who receives chemotherapy?. Annals of Oncology. 19(7), 1231-1241. [Abstract]
• Pestalozzi, B., Zahrieh, D., Mallon, E., Gusterson, B., Price, K., Gelber, R., Holmberg, S., Lindtner, J., Snyder, R., Thürlimann, B., Murray, E., Viale, G., Castiglione-Gertsch, M., Coates, A., Goldhirsch, A. (2008), Distinct Clinical and Prognostic Features of Infiltrating Lobular Carcinoma of the Breast: Combined Results of 15 International Breast Cancer Study Group Clinical Trials. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 26(18), 3006-14. [Abstract]
• Untch, M., Gelber, R., Jackisch, C., Procter, M., Baselga, J., Bell, R., Cameron, D., Bari, M., Smith, I., Leyland-Jones, B., de Azambuja, E., Wermuth, P., Khasanov, R., Feng-Yi, F., Constantin, C., Mayordomo, J., Su, C., Yu, S., Lluch, A., Senkus-Konefka, E., Price, C., Haslbauer, F., Sahui, T., Srimuninnimit, V., Colleoni, M., Coates, A., Piccart-Gebhart, M., Goldhirsch, A. (2008), Estimating the magnitude of trastuzumab effects within patient subgroups in the HERA trial. Annals of oncology : official journal of the European Society for Medical Oncology / ESMO. 19(6), 1090-6. [Abstract]
• Wapnir, I., Aebi, S., Geyer, C., Zahrieh, D., Gelber, R., Anderson, S., Robidoux, A., Bernhard, J., Maibach, R., Castiglione-Gertsch, M., Coates, A., Piccart, M., Clemons, M., Costantino, J., Wolmark, N. (2008), A randomized clinical trial of adjuvant chemotherapy for radically resected locoregional relapse of breast cancer: IBCSG 27-02, BIG 1-02, and NSABP B-37. Clinical Breast Cancer. 8(3), 287-292. [Abstract]
• Crivellari, D., Sun, Z., Coates, A., Price, K., Thürlimann, B., Mouridsen, H., Mauriac, L., Forbes, J., Paridaens, R., Castiglione-Gertsch, M., Gelber, R., Colleoni, M., Láng, I., Del Mastro, L., Gladieff, L., Rabaglio, M., Smith, I., Chirgwin, J., Goldhirsch, A. (2008), Letrozole compared with tamoxifen for elderly patients with endocrine-responsive early breast cancer: the BIG 1-98 trial. Journal of Clinical Oncology. 26(12), 1972-1979. [Abstract]
• Ravaioli, A., Monti, F., Regan, M., Maffini, F., Mastropasqua, M., Spataro, V., Castiglione-Gertsch, M., Panzini, I., Gianni, L., Goldhirsch, A., Coates, A., Price, K., Gusterson, B., Viale, G. (2008), p27 and Skp2 immunoreactivity and its clinical significance with endocrine and chemo-endocrine treatments in node-negative early breast cancer. Annals of oncology. 19(4), 660-668. [Abstract]
• Viale, G., Regan, M., Maiorano, E., Mastropasqua, M., Golouh, R., Perin, T., Brown, R., Kovács, A., Pillay, K., Ohlschlegel, C., Braye, S., Grigolato, P., Rusca, T., Gelber, R., Castiglione-Gertsch, M., Price, K., Goldhirsch, A., Gusterson, B., Coates, A. (2008), Chemoendocrine compared with endocrine adjuvant therapies for node-negative breast cancer: predictive value of centrally reviewed expression of estrogen and progesterone receptors--International Breast Cancer Study Group. Journal of Clinical Oncology. 26(9), 1404-1410. [Abstract]
• Viale, G., Regan, M., Mastropasqua, M., Maffini, F., Maiorano, E., Colleoni, M., Price, K., Golouh, R., Perin, T., Brown, R., Kovács, A., Pillay, K., Ohlschlegel, C., Gusterson, B., Castiglione-Gertsch, M., Gelber, R., Goldhirsch, A., Coates, A. (2008), Predictive value of tumor Ki-67 expression in two randomized trials of adjuvant chemoendocrine therapy for node-negative breast cancer. Journal of the National Cancer Institute. 100(3), 207-212. [Abstract]
• Bernhard, J., Zahrieh, D., Zhang, J., Martinelli, G., Basser, R., Hürny, C., Forbes, J., Aebi, S., Yeo, W., Thürlimann, B., Green, M., Colleoni, M., Gelber, R., Castiglione-Gertsch, M., Price, K., Goldhirsch, A., Coates, A. (2008), Quality of life and quality-adjusted survival (Q-TWiST) in patients receiving dose-intensive or standard dose chemotherapy for high-risk primary breast cancer. British journal of cancer. 98(1), 25-33. [Abstract]
• Early Breast Cancer Trialists' Collaborative Group, Z., Clarke, M., Coates, A., Darby, S., Davies, C., Gelber, R., Godwin, J., Goldhirsch, A., Gray, R., Peto, R., Pritchard, K., Wood, W. (2008), Adjuvant chemotherapy in oestrogen-receptor-poor breast cancer: patient-level meta-analysis of randomised trials. Lancet. 371(9606), 29-40. [Abstract]
• Gianni, L., Cole, B., Panzini, I., Snyder, R., Holmberg, S., Byrne, M., Crivellari, D., Colleoni, M., Aebi, S., Simoncini, E., Pagani, O., Castiglione-Gertsch, M., Price, K., Goldhirsch, A., Coates, A., Ravaioli, A. (2008), Anemia during adjuvant non-taxane chemotherapy for early breast cancer: Incidence and risk factors from two trials of the International Breast Cancer Study Group. Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer. 16(1), 67-74. [Abstract]
• Rasmussen, B., Regan, M., Lykkesfeldt, A., Dell'Orto, P., Del Curto, B., Henriksen, K., Mastropasqua, M., Price, K., Méry, E., Lacroix-Triki, M., Braye, S., Altermatt, H., Gelber, R., Castiglione-Gertsch, M., Goldhirsch, A., Gusterson, B., Thürlimann, B., Coates, A., Viale, G. (2008), Adjuvant letrozole versus tamoxifen according to centrally-assessed ERBB2 status for postmenopausal women with endocrine-responsive early breast cancer: supplementary results from the BIG 1-98 randomised trial. The Lancet oncology. 9(1), 23-28. [Abstract]

2007

• Mouridsen, H., Keshaviah, A., Coates, A., Rabaglio, M., Castiglione-Gertsch, M., Sun, Z., Thürlimann, B., Mauriac, L., Forbes, J., Paridaens, R., Gelber, R., Colleoni, M., Smith, I., Price, K., Goldhirsch, A. (2007), Cardiovascular Adverse Events During Adjuvant Endocrine Therapy for Early Breast Cancer Using Letrozole or Tamoxifen: Safety Analysis of BIG 1-98 Trial. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 25(36), 5715-22. [Abstract]
• Viale, G., Regan, M., Maiorano, E., Mastropasqua, M., Dell'orto, P., Bruun Rasmussen, B., Raffoul, J., Neven, P., Orosz, Z., Braye, S., Ohlschlegel, C., Thürlimann, B., Gelber, R., Castiglione-Gertsch, M., Price, K., Goldhirsch, A., Gusterson, B., Coates, A. (2007), Prognostic and Predictive Value of Centrally Reviewed Expression of Estrogen and Progesterone Receptors in a Randomized Trial Comparing Letrozole and Tamoxifen Adjuvant Therapy for Postmenopausal Women With Early Breast Cancer: Results From the BIG 1-98 Collaborative Groups. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 25(25), 3846-52. [Abstract]
• Goldhirsch, A., Wood, W., Gelber, R., Coates, A., Thürlimann, B., Senn, H. (2007), Progress and promise: highlights of the international expert consensus on the primary therapy of early breast cancer 2007. Annals of oncology : official journal of the European Society for Medical Oncology / ESMO. 18(7), 1133-1144. [Abstract]
• Colleoni, M., Gelber, S., Simoncini, E., Pagani, O., Gelber, R., Price, K., Castiglione-Gertsch, M., Coates, A., Goldhirsch, A. (2007), Effects of a treatment gap during adjuvant chemotherapy in node-positive breast cancer: results of International Breast Cancer Study Group (IBCSG) Trials 13-93 and 14-93. Annals of oncology : official journal of the European Society for Medical Oncology / ESMO. 18(7), 1177-1184. [Abstract]
• Karlsson, P., Cole, B., Price, K., Coates, A., Castiglione-Gertsch, M., Gusterson, B., Murray, E., Lindtner, J., Collins, J., Holmberg, S., Fey, M., Thürlimann, B., Crivellari, D., Forbes, J., Gelber, R., Goldhirsch, A., Wallgren, A. (2007), The role of the number of uninvolved lymph nodes in predicting locoregional recurrence in breast cancer. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 25(15), 2019-2026. [Abstract]
• Mauriac, L., Keshaviah, A., Debled, M., Mouridsen, H., Forbes, J., Thürlimann, B., Paridaens, R., Monnier, A., Láng, I., Wardley, A., Nogaret, J., Gelber, R., Castiglione-Gertsch, M., Price, K., Coates, A., Smith, I., Viale, G., Rabaglio, M., Zabaznyi, N., Goldhirsch, A. (2007), Predictors of early relapse in postmenopausal women with hormone receptor-positive breast cancer in the BIG 1-98 trial. Annals of oncology : official journal of the European Society for Medical Oncology / ESMO. 18(5), 859-867. [Abstract]
• Keshaviah, A., Dellapasqua, S., Rotmensz, N., Lindtner, J., Crivellari, D., Collins, J., Colleoni, M., Thürlimann, B., Mendiola, C., Aebi, S., Price, K., Pagani, O., Simoncini, E., Castiglione Gertsch, M., Gelber, R., Coates, A., Goldhirsch, A. (2007), CA15-3 and alkaline phosphatase as predictors for breast cancer recurrence: a combined analysis of seven International Breast Cancer Study Group trials. Annals of oncology : official journal of the European Society for Medical Oncology / ESMO. 18(4), 701-708. [Abstract]
• Piccart, M., Goldhirsch, A., Wood, W., Pritchard, K., Baselga, J., Reaby, L., Kössler, I., Kyriakides, S., Norton, L., Coates, A. (2007), Keeping faith with trial volunteers. Nature. 446(7132), 137-138. [Abstract]
• Coombes, R., Kilburn, L., Snowdon, C., Paridaens, R., Coleman, R., Jones, S., Jassem, J., Van de Velde, C., Delozier, T., Alvarez, I., Del Mastro, L., Ortmann, O., Diedrich, K., Coates, A., Bajetta, E., Holmberg, S., Dodwell, D., Mickiewicz, E., Andersen, J., Lønning, P., Cocconi, G., Forbes, J., Castiglione, M., Stuart, N., Stewart, A., Fallowfield, L., Bertelli, G., Hall, E., Bogle, R., Carpentieri, M., Colajori, E., Subar, M., Ireland, E., Bliss, J. (2007), Survival and safety of exemestane versus tamoxifen after 2-3 years' tamoxifen treatment (Intergroup Exemestane Study): a randomised controlled trial. Lancet. 369(9561), 559-570. [Abstract]
• Coates, A., Keshaviah, A., Thürlimann, B., Mouridsen, H., Mauriac, L., Forbes, J., Paridaens, R., Castiglione-Gertsch, M., Gelber, R., Colleoni, M., Láng, I., Del Mastro, L., Smith, I., Chirgwin, J., Nogaret, J., Pienkowski, T., Wardley, A., Jakobsen, E., Price, K., Goldhirsch, A. (2007), Five years of letrozole compared with tamoxifen as initial adjuvant therapy for postmenopausal women with endocrine-responsive early breast cancer: update of study BIG 1-98. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 25(5), 486-492. [Abstract]
• Bernhard, J., Zahrieh, D., Castiglione-Gertsch, M., Hürny, C., Gelber, R., Forbes, J., Murray, E., Collins, J., Aebi, S., Thürlimann, B., Price, K., Goldhirsch, A., Coates, A. (2007), Impact of Adjuvant Chemotherapy Followed By Goserelin Compared With Either Modality Alone on Amenorrhea, Hot Flashes, and Quality of Life in Premenopausal Patients With Lymph Node-Negative Breast Cancer: Results on the Effect of Age From the International Breast Cancer Study Group. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 25, 263-70. [Abstract]
• Duric, V., Butow, P., Sharpe, L., Boyle, F., Beith, J., Wilcken, N., Heritier, S., Coates, A., John Simes, R., Stockler, M. (2007), Psychosocial factors and patients' preferences for adjuvant chemotherapy in early breast cancer. Psycho-oncology. 16, 48-59. [Abstract]